Dose Escalation Study of Clofarabine in Combination With Cytarabine (Ara-C) and G-CSF Priming for Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Clofarabine; Cytarabine; Filgrastim
- Indications Acute myeloid leukaemia; Acute promyelocytic leukaemia
- Focus Adverse reactions
- 09 Mar 2018 Biomarkers information updated
- 16 Aug 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 27 Feb 2008 New trial record.